The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

Now published in the journal Science, this research is already gaining international ... This could open uncharted regions of chemical space in drug discovery." According to Sharma, this skeletal ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Find out about the journal aims and scope. To allow immediate global open access to all articles, npj Drug Discovery levies an article processing charge (APC). Current APCs and waiver information ...

Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare sector.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

a new injectable drug that demonstrated a 96% reduction in infection risk. The prestigious journal Science recognized Lenacapavir as the 'Discovery of the Year' for 2024 due to its contributions ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...